Myocarditis is recognized as a rare but serious adverse reaction to messenger RNA (mRNA) vaccination against COVID-19.
RNA technology is regarded as one of the newest frontiers in medicine, but in fact a primordial innovator got there way ...
The U.S. helped pioneer the technology, but new funding cuts may shift breakthroughs — and industry leadership — overseas.
Promega authorizes UBC RNA & Formulation Core to distribute NanoLuc-encoding mRNA, expanding researcher access for LNP and ...
The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.
Indian American physician-scientist Dr. Vinod Balachandran says mRNA vaccines may reduce risk of disease coming back after ...
Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in ...
Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice ...
Researchers decoded how mRNA is transported in Ustilago maydis cells. They identified how binding motifs ensure accurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results